PALATIN TECHNOLOGIES, INC. Derivative, Gain (Loss) on Derivative, Net
PALATIN TECHNOLOGIES, INC. (PTN) reported Derivative, Gain (Loss) on Derivative, Net of $0 for the 3-month period ending 2024-12-31, per its 10-Q filed 2025-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2025-02-13
- PALATIN TECHNOLOGIES, INC. derivative, gain (loss) on derivative, net for the quarter ending 2024-12-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. derivative, gain (loss) on derivative, net for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. derivative, gain (loss) on derivative, net for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. derivative, gain (loss) on derivative, net for the quarter ending 2024-03-31 was $429.03K.
- PALATIN TECHNOLOGIES, INC. derivative, gain (loss) on derivative, net for fiscal 2024 was -$6.96M, a 250.68% decline from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. derivative, gain (loss) on derivative, net for fiscal 2023 was $4.62M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-Q · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | $0.00 derived: sum of 3 quarters · filed 2025-02-13 | $429.03K derived: sum of 4 quarters · filed 2025-02-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $429.03K derived: sum of 3 quarters · filed 2024-11-14 | -$7.64M derived: sum of 4 quarters · filed 2025-02-13 |
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $429.03K derived: sum of 2 quarters · filed 2024-09-30 | -$7.64M derived: sum of 3 quarters · filed 2025-02-13 | -$6.96M 10-K · filed 2024-09-30 |
| 2024-03-31 | $429.03K 10-Q · filed 2024-05-15 | -$7.64M derived: sum of 2 quarters · filed 2025-02-13 | -$6.96M 10-Q · filed 2024-05-15 | -$6.07M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-12-31 | -$8.07M 10-Q · filed 2025-02-13 | -$7.39M 10-Q · filed 2025-02-13 | -$6.50M derived: sum of 3 quarters · filed 2025-02-13 | -$8.02M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $682.40K 10-Q · filed 2024-11-14 | $1.58M derived: sum of 2 quarters · filed 2024-11-14 | $56.00K derived: sum of 3 quarters · filed 2024-11-14 | $5.30M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $895.02K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$626.40K derived: sum of 2 quarters · filed 2024-09-30 | $4.62M derived: sum of 3 quarters · filed 2024-09-30 | $4.62M 10-K · filed 2024-09-30 |
| 2023-03-31 | -$1.52M 10-Q · filed 2024-05-15 | $3.73M derived: sum of 2 quarters · filed 2024-05-15 | $3.73M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $5.25M 10-Q · filed 2024-02-14 | $5.25M 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |